IBDEI1NI ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,26366,0)
;;=E10.44^^107^1240^1
;;^UTILITY(U,$J,358.3,26366,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26366,1,3,0)
;;=3^DM Type 1 w/ Diab Amyotrophy
;;^UTILITY(U,$J,358.3,26366,1,4,0)
;;=4^E10.44
;;^UTILITY(U,$J,358.3,26366,2)
;;=^5002608
;;^UTILITY(U,$J,358.3,26367,0)
;;=E10.49^^107^1240^25
;;^UTILITY(U,$J,358.3,26367,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26367,1,3,0)
;;=3^DM Type 1 w/ Oth Diab Neurological Compl
;;^UTILITY(U,$J,358.3,26367,1,4,0)
;;=4^E10.49
;;^UTILITY(U,$J,358.3,26367,2)
;;=^5002609
;;^UTILITY(U,$J,358.3,26368,0)
;;=E10.59^^107^1240^22
;;^UTILITY(U,$J,358.3,26368,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26368,1,3,0)
;;=3^DM Type 1 w/ Oth Circulatory Compl
;;^UTILITY(U,$J,358.3,26368,1,4,0)
;;=4^E10.59
;;^UTILITY(U,$J,358.3,26368,2)
;;=^5002612
;;^UTILITY(U,$J,358.3,26369,0)
;;=E10.610^^107^1240^9
;;^UTILITY(U,$J,358.3,26369,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26369,1,3,0)
;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,26369,1,4,0)
;;=4^E10.610
;;^UTILITY(U,$J,358.3,26369,2)
;;=^5002613
;;^UTILITY(U,$J,358.3,26370,0)
;;=E10.618^^107^1240^23
;;^UTILITY(U,$J,358.3,26370,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26370,1,3,0)
;;=3^DM Type 1 w/ Oth Diab Arthropathy
;;^UTILITY(U,$J,358.3,26370,1,4,0)
;;=4^E10.618
;;^UTILITY(U,$J,358.3,26370,2)
;;=^5002614
;;^UTILITY(U,$J,358.3,26371,0)
;;=E10.630^^107^1240^30
;;^UTILITY(U,$J,358.3,26371,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26371,1,3,0)
;;=3^DM Type 1 w/ Peridontal Disease
;;^UTILITY(U,$J,358.3,26371,1,4,0)
;;=4^E10.630
;;^UTILITY(U,$J,358.3,26371,2)
;;=^5002619
;;^UTILITY(U,$J,358.3,26372,0)
;;=E10.638^^107^1240^27
;;^UTILITY(U,$J,358.3,26372,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26372,1,3,0)
;;=3^DM Type 1 w/ Oth Oral Compl
;;^UTILITY(U,$J,358.3,26372,1,4,0)
;;=4^E10.638
;;^UTILITY(U,$J,358.3,26372,2)
;;=^5002620
;;^UTILITY(U,$J,358.3,26373,0)
;;=E10.641^^107^1240^15
;;^UTILITY(U,$J,358.3,26373,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26373,1,3,0)
;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
;;^UTILITY(U,$J,358.3,26373,1,4,0)
;;=4^E10.641
;;^UTILITY(U,$J,358.3,26373,2)
;;=^5002621
;;^UTILITY(U,$J,358.3,26374,0)
;;=E10.649^^107^1240^16
;;^UTILITY(U,$J,358.3,26374,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26374,1,3,0)
;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,26374,1,4,0)
;;=4^E10.649
;;^UTILITY(U,$J,358.3,26374,2)
;;=^5002622
;;^UTILITY(U,$J,358.3,26375,0)
;;=E10.65^^107^1240^14
;;^UTILITY(U,$J,358.3,26375,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26375,1,3,0)
;;=3^DM Type 1 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,26375,1,4,0)
;;=4^E10.65
;;^UTILITY(U,$J,358.3,26375,2)
;;=^5002623
;;^UTILITY(U,$J,358.3,26376,0)
;;=E10.69^^107^1240^29
;;^UTILITY(U,$J,358.3,26376,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26376,1,3,0)
;;=3^DM Type 1 w/ Oth Spec Compl
;;^UTILITY(U,$J,358.3,26376,1,4,0)
;;=4^E10.69
;;^UTILITY(U,$J,358.3,26376,2)
;;=^5002624
;;^UTILITY(U,$J,358.3,26377,0)
;;=E10.8^^107^1240^33
;;^UTILITY(U,$J,358.3,26377,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26377,1,3,0)
;;=3^DM Type 1 w/ Unspec Compl
;;^UTILITY(U,$J,358.3,26377,1,4,0)
;;=4^E10.8
;;^UTILITY(U,$J,358.3,26377,2)
;;=^5002625
;;^UTILITY(U,$J,358.3,26378,0)
;;=E10.9^^107^1240^34
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1NI 3760 printed Nov 22, 2024@17:22:20 Page 2
IBDEI1NI ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,26366,0)
+2 ;;=E10.44^^107^1240^1
+3 ;;^UTILITY(U,$J,358.3,26366,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,26366,1,3,0)
+6 ;;=3^DM Type 1 w/ Diab Amyotrophy
+7 ;;^UTILITY(U,$J,358.3,26366,1,4,0)
+8 ;;=4^E10.44
+9 ;;^UTILITY(U,$J,358.3,26366,2)
+10 ;;=^5002608
+11 ;;^UTILITY(U,$J,358.3,26367,0)
+12 ;;=E10.49^^107^1240^25
+13 ;;^UTILITY(U,$J,358.3,26367,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,26367,1,3,0)
+16 ;;=3^DM Type 1 w/ Oth Diab Neurological Compl
+17 ;;^UTILITY(U,$J,358.3,26367,1,4,0)
+18 ;;=4^E10.49
+19 ;;^UTILITY(U,$J,358.3,26367,2)
+20 ;;=^5002609
+21 ;;^UTILITY(U,$J,358.3,26368,0)
+22 ;;=E10.59^^107^1240^22
+23 ;;^UTILITY(U,$J,358.3,26368,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,26368,1,3,0)
+26 ;;=3^DM Type 1 w/ Oth Circulatory Compl
+27 ;;^UTILITY(U,$J,358.3,26368,1,4,0)
+28 ;;=4^E10.59
+29 ;;^UTILITY(U,$J,358.3,26368,2)
+30 ;;=^5002612
+31 ;;^UTILITY(U,$J,358.3,26369,0)
+32 ;;=E10.610^^107^1240^9
+33 ;;^UTILITY(U,$J,358.3,26369,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,26369,1,3,0)
+36 ;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
+37 ;;^UTILITY(U,$J,358.3,26369,1,4,0)
+38 ;;=4^E10.610
+39 ;;^UTILITY(U,$J,358.3,26369,2)
+40 ;;=^5002613
+41 ;;^UTILITY(U,$J,358.3,26370,0)
+42 ;;=E10.618^^107^1240^23
+43 ;;^UTILITY(U,$J,358.3,26370,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,26370,1,3,0)
+46 ;;=3^DM Type 1 w/ Oth Diab Arthropathy
+47 ;;^UTILITY(U,$J,358.3,26370,1,4,0)
+48 ;;=4^E10.618
+49 ;;^UTILITY(U,$J,358.3,26370,2)
+50 ;;=^5002614
+51 ;;^UTILITY(U,$J,358.3,26371,0)
+52 ;;=E10.630^^107^1240^30
+53 ;;^UTILITY(U,$J,358.3,26371,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,26371,1,3,0)
+56 ;;=3^DM Type 1 w/ Peridontal Disease
+57 ;;^UTILITY(U,$J,358.3,26371,1,4,0)
+58 ;;=4^E10.630
+59 ;;^UTILITY(U,$J,358.3,26371,2)
+60 ;;=^5002619
+61 ;;^UTILITY(U,$J,358.3,26372,0)
+62 ;;=E10.638^^107^1240^27
+63 ;;^UTILITY(U,$J,358.3,26372,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,26372,1,3,0)
+66 ;;=3^DM Type 1 w/ Oth Oral Compl
+67 ;;^UTILITY(U,$J,358.3,26372,1,4,0)
+68 ;;=4^E10.638
+69 ;;^UTILITY(U,$J,358.3,26372,2)
+70 ;;=^5002620
+71 ;;^UTILITY(U,$J,358.3,26373,0)
+72 ;;=E10.641^^107^1240^15
+73 ;;^UTILITY(U,$J,358.3,26373,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,26373,1,3,0)
+76 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
+77 ;;^UTILITY(U,$J,358.3,26373,1,4,0)
+78 ;;=4^E10.641
+79 ;;^UTILITY(U,$J,358.3,26373,2)
+80 ;;=^5002621
+81 ;;^UTILITY(U,$J,358.3,26374,0)
+82 ;;=E10.649^^107^1240^16
+83 ;;^UTILITY(U,$J,358.3,26374,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,26374,1,3,0)
+86 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
+87 ;;^UTILITY(U,$J,358.3,26374,1,4,0)
+88 ;;=4^E10.649
+89 ;;^UTILITY(U,$J,358.3,26374,2)
+90 ;;=^5002622
+91 ;;^UTILITY(U,$J,358.3,26375,0)
+92 ;;=E10.65^^107^1240^14
+93 ;;^UTILITY(U,$J,358.3,26375,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,26375,1,3,0)
+96 ;;=3^DM Type 1 w/ Hyperglycemia
+97 ;;^UTILITY(U,$J,358.3,26375,1,4,0)
+98 ;;=4^E10.65
+99 ;;^UTILITY(U,$J,358.3,26375,2)
+100 ;;=^5002623
+101 ;;^UTILITY(U,$J,358.3,26376,0)
+102 ;;=E10.69^^107^1240^29
+103 ;;^UTILITY(U,$J,358.3,26376,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,26376,1,3,0)
+106 ;;=3^DM Type 1 w/ Oth Spec Compl
+107 ;;^UTILITY(U,$J,358.3,26376,1,4,0)
+108 ;;=4^E10.69
+109 ;;^UTILITY(U,$J,358.3,26376,2)
+110 ;;=^5002624
+111 ;;^UTILITY(U,$J,358.3,26377,0)
+112 ;;=E10.8^^107^1240^33
+113 ;;^UTILITY(U,$J,358.3,26377,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,26377,1,3,0)
+116 ;;=3^DM Type 1 w/ Unspec Compl
+117 ;;^UTILITY(U,$J,358.3,26377,1,4,0)
+118 ;;=4^E10.8
+119 ;;^UTILITY(U,$J,358.3,26377,2)
+120 ;;=^5002625
+121 ;;^UTILITY(U,$J,358.3,26378,0)
+122 ;;=E10.9^^107^1240^34
